Towards Personalized Vaccines

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Oct 18

PMID 39421749

Authors

Davide Montin

Veronica Santilli

Alessandra Beni

Giorgio Costagliola

Baldassarre Martire

Maria Felicia Mastrototaro

Giorgio Ottaviano

Caterina Rizzo

Mayla Sgrulletti

Michele Miraglia Del Giudice

Viviana Moschese

Affiliations

Soon will be listed here.

Abstract

The emergence of vaccinomics and system vaccinology represents a transformative shift in immunization strategies, advocating for personalized vaccines tailored to individual genetic and immunological profiles. Integrating insights from genomics, transcriptomics, proteomics, and immunology, personalized vaccines offer the promise of enhanced efficacy and safety, revolutionizing the field of vaccinology. However, the development of personalized vaccines presents multifaceted challenges, including technical, ethical, economic, and regulatory considerations. Addressing these challenges is essential to ensure equitable access and safety of personalized vaccination strategies. Despite these hurdles, the potential of personalized vaccines to optimize responses and mitigate disease burden underscores the significance of ongoing research and collaboration in advancing precision medicine in immunization.

References

Hasin Y, Seldin M, Lusis A . Multi-omics approaches to disease. Genome Biol. 2017; 18(1):83. PMC: 5418815. DOI: 10.1186/s13059-017-1215-1. View

Bravi B . Development and use of machine learning algorithms in vaccine target selection. NPJ Vaccines. 2024; 9(1):15. PMC: 10798987. DOI: 10.1038/s41541-023-00795-8. View

Johnson K, Ovsyannikova I, Mason C, Bergen 3rd H, Poland G . Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development. Vaccine. 2009; 28(1):38-47. PMC: 2787804. DOI: 10.1016/j.vaccine.2009.09.126. View

Cotugno N, Neri A, Sanna M, Santilli V, Manno E, Pascucci G . Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine. JCI Insight. 2024; 9(10). PMC: 11141905. DOI: 10.1172/jci.insight.177182. View

Querec T, Akondy R, Lee E, Cao W, Nakaya H, Teuwen D . Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol. 2008; 10(1):116-125. PMC: 4049462. DOI: 10.1038/ni.1688. View

Ovsyannikova I, Johnson K, Bergen 3rd H, Poland G . Mass spectrometry and peptide-based vaccine development. Clin Pharmacol Ther. 2007; 82(6):644-52. DOI: 10.1038/sj.clpt.6100389. View

Franco L, Bucasas K, Wells J, Nino D, Wang X, Zapata G . Integrative genomic analysis of the human immune response to influenza vaccination. Elife. 2013; 2:e00299. PMC: 3713456. DOI: 10.7554/eLife.00299. View

Priest D, Ebihara T, Tulyeu J, Sondergaard J, Sakakibara S, Sugihara F . Atypical and non-classical CD45RB memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-19. Nat Commun. 2024; 15(1):6811. PMC: 11315995. DOI: 10.1038/s41467-024-50997-4. View

Parhiz H, Atochina-Vasserman E, Weissman D . mRNA-based therapeutics: looking beyond COVID-19 vaccines. Lancet. 2024; 403(10432):1192-1204. DOI: 10.1016/S0140-6736(23)02444-3. View

10.

Moin A, Ullah M, Patil R, Faruqui N, Araf Y, Das S . A computational approach to design a polyvalent vaccine against human respiratory syncytial virus. Sci Rep. 2023; 13(1):9702. PMC: 10272159. DOI: 10.1038/s41598-023-35309-y. View

11.

Dhiman N, Poland G, Cunningham J, Jacobson R, Ovsyannikova I, Vierkant R . Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol. 2007; 120(3):666-72. DOI: 10.1016/j.jaci.2007.04.036. View

12.

Chattopadhyay P, Roederer M . Cytometry: today's technology and tomorrow's horizons. Methods. 2012; 57(3):251-8. PMC: 3374038. DOI: 10.1016/j.ymeth.2012.02.009. View

13.

Chan C, Chan K, Chua C, Nur Hazirah S, Ghosh S, Ooi E . Early molecular correlates of adverse events following yellow fever vaccination. JCI Insight. 2017; 2(19). PMC: 5841882. DOI: 10.1172/jci.insight.96031. View

14.

Rauch S, Jasny E, Schmidt K, Petsch B . New Vaccine Technologies to Combat Outbreak Situations. Front Immunol. 2018; 9:1963. PMC: 6156540. DOI: 10.3389/fimmu.2018.01963. View

15.

Poland G, Ovsyannikova I, Jacobson R . Immunogenetics of seasonal influenza vaccine response. Vaccine. 2009; 26 Suppl 4:D35-40. PMC: 2610683. DOI: 10.1016/j.vaccine.2008.07.065. View

16.

Nishida N, Sugiyama M, Sawai H, Nishina S, Sakai A, Ohashi J . Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine. Hepatology. 2018; 68(3):848-858. PMC: 6175380. DOI: 10.1002/hep.29876. View

17.

Poland G, Ovsyannikova I, Kennedy R . Personalized vaccinology: A review. Vaccine. 2017; 36(36):5350-5357. PMC: 5792371. DOI: 10.1016/j.vaccine.2017.07.062. View

18.

Gomez-Carballa A, Barral-Arca R, Cebey-Lopez M, Curras-Tuala M, Pischedda S, Gomez-Rial J . Host Transcriptomic Response Following Administration of Rotavirus Vaccine in Infants' Mimics Wild Type Infection. Front Immunol. 2021; 11:580219. PMC: 7859632. DOI: 10.3389/fimmu.2020.580219. View

19.

Pulendran B, Li S, Nakaya H . Systems vaccinology. Immunity. 2010; 33(4):516-29. PMC: 3001343. DOI: 10.1016/j.immuni.2010.10.006. View

20.

Stubbington M, Rozenblatt-Rosen O, Regev A, Teichmann S . Single-cell transcriptomics to explore the immune system in health and disease. Science. 2017; 358(6359):58-63. PMC: 5654495. DOI: 10.1126/science.aan6828. View